We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
On today’s episode of the Zacks Friday Finish Line, Associate Stock Strategist Ryan McQueeney and Editor Maddy Johnson take on this week’s biggest stories, including Grubhub’s shiny new acquisition, Spotify’s impressive user growth, and mixed reactions to earnings announcements from FANG stocks and oil giants.
Make sure to subscribe and leave the show a rating on Apple Podcasts!
First, the Finish Line team discussed Grubhub’s latest earnings report, which saw the food delivery giant post better-than-expected results and announce the acquisition of LevelUp, a payments and customer rewards company. Grubhub shares soared in the wake of the report, and Maddy and Ryan discuss why this might have more to do with the benefits of the LevelUp buy than any current growth figures.
Next, the hosts chatted about Spotify’s (SPOT - Free Report) second earnings report as a publicly-traded company. The music streaming giant missed some revenue estimates, but investors were far more interested in its impressive user growth figures. Maddy and Ryan discuss setting expectations for Spotify and interpreting its current user numbers heading forward.
Maddy and Ryan also covered this week’s top tech reports from FANG member Facebook , Amazon (AMZN - Free Report) , and Alphabet (GOOGL - Free Report) .
Google parent Alphabet kicked things off strong this week, posting staggering revenue growth for a company of its size and stature. However, the wind was taken out of the FANG sails after Facebook reported a rare double miss and suffered a historically bad day of trading.
Still, Amazon surprised to the upside and looked ready to rejuvenate the group later in the week. Maddy and Ryan recap the key facts from all of these reports, so make sure to check out the episode to hear more!
Finally, the hosts wrapped up the episode by checking in on the mixed earnings results from oil behemoths Royal Dutch Shell , Exxon Mobil (XOM - Free Report) , Chevron (CVX - Free Report) , which gave updates on the state of oil production and share repurchase programs.
Tune in to hear what the Finish Line team had to say about these major oil stocks!
As a reminder, if you feel that we missed something, or if you want us to cover a different story, shoot us an email at podcast@zacks.com. Make sure to check out all of our other audio content at zacks.com/podcasts, and remember to subscribe and leave us a rating on Apple Podcasts.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Image: Bigstock
Mixed FANG Earnings, Oil Stocks Stutter, & Grubhub Goes Shopping
On today’s episode of the Zacks Friday Finish Line, Associate Stock Strategist Ryan McQueeney and Editor Maddy Johnson take on this week’s biggest stories, including Grubhub’s shiny new acquisition, Spotify’s impressive user growth, and mixed reactions to earnings announcements from FANG stocks and oil giants.
Make sure to subscribe and leave the show a rating on Apple Podcasts!
First, the Finish Line team discussed Grubhub’s latest earnings report, which saw the food delivery giant post better-than-expected results and announce the acquisition of LevelUp, a payments and customer rewards company. Grubhub shares soared in the wake of the report, and Maddy and Ryan discuss why this might have more to do with the benefits of the LevelUp buy than any current growth figures.
Next, the hosts chatted about Spotify’s (SPOT - Free Report) second earnings report as a publicly-traded company. The music streaming giant missed some revenue estimates, but investors were far more interested in its impressive user growth figures. Maddy and Ryan discuss setting expectations for Spotify and interpreting its current user numbers heading forward.
Maddy and Ryan also covered this week’s top tech reports from FANG member Facebook , Amazon (AMZN - Free Report) , and Alphabet (GOOGL - Free Report) .
Google parent Alphabet kicked things off strong this week, posting staggering revenue growth for a company of its size and stature. However, the wind was taken out of the FANG sails after Facebook reported a rare double miss and suffered a historically bad day of trading.
Still, Amazon surprised to the upside and looked ready to rejuvenate the group later in the week. Maddy and Ryan recap the key facts from all of these reports, so make sure to check out the episode to hear more!
Finally, the hosts wrapped up the episode by checking in on the mixed earnings results from oil behemoths Royal Dutch Shell , Exxon Mobil (XOM - Free Report) , Chevron (CVX - Free Report) , which gave updates on the state of oil production and share repurchase programs.
Tune in to hear what the Finish Line team had to say about these major oil stocks!
As a reminder, if you feel that we missed something, or if you want us to cover a different story, shoot us an email at podcast@zacks.com. Make sure to check out all of our other audio content at zacks.com/podcasts, and remember to subscribe and leave us a rating on Apple Podcasts.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>